Vanguard Group’s Atea Pharmaceuticals AVIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $17.6M | Buy |
4,887,221
+159,519
| +3% | +$574K | ﹤0.01% | 2614 |
|
|
2025
Q1 | $14.1M | Buy |
4,727,702
+60,848
| +1% | +$182K | ﹤0.01% | 2664 |
|
|
2024
Q4 | $15.6M | Sell |
4,666,854
-184,364
| -4% | -$618K | ﹤0.01% | 2709 |
|
|
2024
Q3 | $16.3M | Buy |
4,851,218
+126,813
| +3% | +$425K | ﹤0.01% | 2701 |
|
|
2024
Q2 | $15.6M | Buy |
4,724,405
+1,883
| +0% | +$6.23K | ﹤0.01% | 2690 |
|
|
2024
Q1 | $19.1M | Buy |
4,722,522
+122,812
| +3% | +$496K | ﹤0.01% | 2626 |
|
|
2023
Q4 | $14M | Buy |
4,599,710
+26,270
| +0.6% | +$80.1K | ﹤0.01% | 2768 |
|
|
2023
Q3 | $13.7M | Buy |
4,573,440
+55,841
| +1% | +$168K | ﹤0.01% | 2705 |
|
|
2023
Q2 | $16.9M | Sell |
4,517,599
-69,582
| -2% | -$260K | ﹤0.01% | 2665 |
|
|
2023
Q1 | $15.4M | Sell |
4,587,181
-1,502,341
| -25% | -$5.03M | ﹤0.01% | 2716 |
|
|
2022
Q4 | $29.3M | Sell |
6,089,522
-1,494,734
| -20% | -$7.19M | ﹤0.01% | 2449 |
|
|
2022
Q3 | $43.2M | Buy |
7,584,256
+403,971
| +6% | +$2.3M | ﹤0.01% | 2254 |
|
|
2022
Q2 | $51M | Buy |
7,180,285
+451,082
| +7% | +$3.2M | ﹤0.01% | 2187 |
|
|
2022
Q1 | $48.6M | Buy |
6,729,203
+947,321
| +16% | +$6.84M | ﹤0.01% | 2321 |
|
|
2021
Q4 | $51.7M | Buy |
5,781,882
+601,927
| +12% | +$5.38M | ﹤0.01% | 2330 |
|
|
2021
Q3 | $182M | Buy |
5,179,955
+643,792
| +14% | +$22.6M | ﹤0.01% | 1666 |
|
|
2021
Q2 | $97.4M | Buy |
4,536,163
+3,429,258
| +310% | +$73.7M | ﹤0.01% | 2013 |
|
|
2021
Q1 | $68.4M | Buy |
1,106,905
+22,378
| +2% | +$1.38M | ﹤0.01% | 2137 |
|
|
2020
Q4 | $45.3M | Buy |
+1,084,527
| New | +$45.3M | ﹤0.01% | 2253 |
|